This morning, Dr. Esra Ogru, co-CEO of Phosphagenics (POH) presented at the Bio-Melbourne Network breakfast.
Her presentation included among products that TPM (targeted penetration matrix) is "currently used in," this item:
"-Novel products; AOD for cellulite reduction"
The logical conclusion that can be drawn from this is that the AOD9604 Cellucreme product has now been successfully formulated.
Moreover, Dr. Ogru noted that Phosphagenics has a commercial or research deal with a "Global cosmetics company". Here again, while by no means a solid conclusion, the logical inference is that something Phosphagenics can offer to a cosmetics giant has attracted interest. Keeping in mind that Phosphagenics has an existing excclusive with Le Metier de Beaute for cosmetics products and with ProPhase Labs for OTC (excluding the cellulite product), then the cellucreme stands out as the logical subject matter of any such interest. It may be the subject of an already-in-place agreement either research or commercial with a global cosmetics giant.
It is likely, in my opinion, that an AOD9604 based anti-cellulite topical application cream is in fact now being tested by one of the biggies.
This is all just speculation, but it is logically based on public statements.
If this does come together, CZD won't be trading for 2 or 3 cents any more.
Add to My Watchlist
What is My Watchlist?